Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning eczematous dermatitis of eyelid
Updated Jan 30, 2026
Amgen has discontinued development of its eczema drug following disappointing Phase 3 trial results, raising concerns about the viability of new autoimmune therapies competing with Dupixent. This decision reflects ongoing challenges in the dermatology pipeline.